IRIS
COSTANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.659
AS - Asia 3.228
EU - Europa 3.062
SA - Sud America 392
AF - Africa 59
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
Totale 26.423
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.548
SG - Singapore 1.411
CN - Cina 818
DE - Germania 456
UA - Ucraina 429
RU - Federazione Russa 425
BR - Brasile 335
IT - Italia 319
HK - Hong Kong 304
SE - Svezia 276
VN - Vietnam 270
IE - Irlanda 261
FR - Francia 223
GB - Regno Unito 220
PL - Polonia 194
FI - Finlandia 125
JP - Giappone 92
KR - Corea 83
CA - Canada 64
BD - Bangladesh 51
IN - India 42
NL - Olanda 27
BE - Belgio 26
AR - Argentina 23
MX - Messico 20
TR - Turchia 20
ZA - Sudafrica 19
ES - Italia 18
IQ - Iraq 14
AT - Austria 12
IL - Israele 12
KG - Kirghizistan 12
PK - Pakistan 12
AU - Australia 11
UZ - Uzbekistan 11
CL - Cile 10
EG - Egitto 9
ID - Indonesia 9
MY - Malesia 9
TN - Tunisia 9
EC - Ecuador 8
EU - Europa 8
PH - Filippine 8
RO - Romania 8
TH - Thailandia 8
CH - Svizzera 7
CO - Colombia 6
KZ - Kazakistan 6
PY - Paraguay 6
SA - Arabia Saudita 6
DK - Danimarca 5
DO - Repubblica Dominicana 5
MA - Marocco 5
NP - Nepal 5
DZ - Algeria 4
HN - Honduras 4
JM - Giamaica 4
LT - Lituania 4
OM - Oman 4
AL - Albania 3
CY - Cipro 3
ET - Etiopia 3
GR - Grecia 3
IR - Iran 3
KE - Kenya 3
PT - Portogallo 3
RS - Serbia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
CZ - Repubblica Ceca 2
GA - Gabon 2
GH - Ghana 2
HR - Croazia 2
JO - Giordania 2
MD - Moldavia 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
VC - Saint Vincent e Grenadine 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BZ - Belize 1
CU - Cuba 1
EE - Estonia 1
FJ - Figi 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 26.414
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.820
Wilmington 3.885
Houston 3.424
Ann Arbor 895
Singapore 826
Fairfield 801
Chandler 635
Ashburn 590
San Jose 409
Seattle 395
Jacksonville 394
Beijing 315
Hong Kong 297
Cambridge 290
Dublin 259
Medford 220
Dearborn 178
New York 177
Kraków 170
The Dalles 137
Santa Clara 128
Dallas 103
Lawrence 102
Los Angeles 97
Zhengzhou 84
Tokyo 74
Hanoi 68
Ho Chi Minh City 68
Mülheim 67
Council Bluffs 64
Moscow 62
Boardman 54
Buffalo 54
Munich 54
Milan 52
San Diego 49
São Paulo 47
Rome 44
Menlo Park 43
Helsinki 35
Lauterbourg 34
San Mateo 34
Chicago 31
Falls Church 31
Shanghai 30
Brussels 24
London 24
Nuremberg 21
Redwood City 21
Atlanta 19
Montreal 19
Brooklyn 18
Hefei 18
Orem 18
Saint Petersburg 17
Columbus 16
Mountain View 16
Nanjing 16
Toronto 16
University Park 15
Warsaw 15
Frankfurt am Main 14
Turin 14
Manchester 13
Stockholm 13
Ankara 12
Chongqing 12
Da Nang 12
Amsterdam 11
Guangzhou 11
Kunming 11
Norwalk 11
Auburn Hills 10
Chennai 10
Hangzhou 10
Jinan 10
Johannesburg 10
Phoenix 10
Pune 10
Redondo Beach 10
San Francisco 10
Belo Horizonte 9
Perugia 9
Poplar 9
Suzhou 9
Boston 8
Changsha 8
Haiphong 8
Nürnberg 8
Verona 8
Wuhan 8
Alexandria 7
City of London 7
Denver 7
Detroit 7
Rio de Janeiro 7
Saint Louis 7
Campinas 6
Elk Grove Village 6
Kuala Lumpur 6
Totale 21.287
Salva come PNG Salva come JPEG
Nome #
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 541
The p53/p63/p73 family of transcription factors: overlapping and distinct functions 540
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 526
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 497
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage 495
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 490
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 489
Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage 474
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 471
Ascorbate up-regulates MLH1 (Mut L homologue-1) and p73: Implications for the cellular response to DNA damage 466
Actinic keratosis treated with an immune response modifier: a case report of six patients 458
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 454
MEK1 inhibition sensitizes primary acute myelogenous leukemia to arsenic trioxide-induced apoptosis 451
IL-21 in the pathogenesis and treatment of skin diseases 445
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 439
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 438
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 434
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 431
Characterization of a new cancer-associated mutant of p53 with a missense mutation (K351N) in the tetramerization domain 429
Structure, function and regulation of p63 and p73 426
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage 423
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 423
Herpes simplex virus disrupts NF-kappa B regulation by blocking its recruitment on the I kappa B alpha promoter and directing the factor on viral genes. 416
Induction of neuronal differentiation by p73 in a neuroblastoma cell line 410
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 410
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 407
Elementi di dermatologia 404
Pathogenic role of interleukin-21 in psoriasis 401
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 397
Zosteriform metastasis of occult bronchogenic carcinoma 381
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 377
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants  and  377
Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis 366
Two new p73 splice variants, gamma and delta, with different transcriptional activity 365
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 359
Zosteriform metastasis of occult bronchogenic carcinoma 355
IL-21, a new player in pathogenesis of psoriasis 355
Psoriasis: from pathogenesis to novel therapeutic approaches 353
Effects of topical methotrexate loaded gold nanoparticle in cutaneous inflammatory mouse model 343
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 342
High-dose Intravenous Immunoglobulin for Severe Drug Reactions: Efficacy in Toxic Epidermal Necrolysis 340
Secukinumab shows high efficacy irrespective of HLA-Cw6 status in patients with moderate to severe plaque-type psoriasis: Results from extension phase of the SUPREME study 255
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 216
Claudin-1 is a p63 target gene with a crucial role in epithelial development 211
Treatment of vitiligo with the 308 nm excimer laser 210
308 nm monochromatic excimer light in the treatment of psoriasis 202
The impact of methodological approaches for presenting long-term clinical data on estimates of efficacy in psoriasis illustrated by three-year treatment data on infliximab 196
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation 196
Safety and efficacy study on etanercept in patients with plaque psoriasis 191
Different applications of monochromatic excimer light in skin diseases 188
Cross-talks in the p53 family - Delta Np63 is an anti-apoptotci target for Delta Np73 alpha and p53 gain-of-function mutants 188
Efalizumab 187
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 177
p63 and p73 transactivate differentiation gene promoters in human keratinocytes 177
A role of p73 in mitotic exit 176
Efficacy of efalizumab in psoriasis patients previously treated with tumour necrosis factor blockers 175
Treasure or artifact: a decade of p63 research speaks for itself 174
p63 induces key target genes required for epidermal morphogenesis 173
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides 173
Moderate and severe plaque psoriasis: Cost-of-illness study in Italy 171
Targeting MEK/MAPK signal transduction module potentiates ATO-induced apoptosis in multiple myeloma cells through multiple signaling pathways 167
Consecutive use of different biological therapies in the treatment of psoriasis [4] 165
Long-term treatment of plaque psoriasis with efalizumab: an Italian experience 160
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 159
Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects 158
RelA/NF-kappa B recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells 156
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 154
Homeobox gene Dlx3 is regulated by p63 during ectoderm development: relevance in the pathogenesis of ectodermal dysplasias 153
Trichostatin A up-regulates p73 and induces Bax-dependent apoptosis in cisplatin-resistant ovarian cancer cells 152
DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes 151
p73 is regulated by phosphorylation at the G2/M transition 150
Safety and efficacy study on etanercept in patients with plaque psoriasis 150
NF-κB, IκB Kinase and Interacting Signal Networks in Squamous Cell Carcinomas 148
Pharmacological treatment of androgenetic alopecia.Result of an observational study 146
Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells 145
Emerging treatments in the management of psoriasis: biological targeting with ustekinumab 144
deltaEF1 repressor controls selectively p53 family members during differentiation 144
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters 144
The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting 143
Differential regulation of E2F1 apoptotic target genes in response to DNA damage 143
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 143
Efficacy and safety of etanercept in psoriasis after switching from other treatments: An observational study 134
Etanercept for the treatment of severe childhood psoriasis [3] 129
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 129
Delta Np63 Knockdown Mice: A Mouse Model for AEC Syndrome 126
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis 124
Assessment of HLA Cw6 genotype and correlation to ustekinumab response in a large cohort of patients with moderate-to-severe psoriasis 122
HLA-Cw6 allele confers sensitivity to efalizumab treatment in psoriasis 120
Pharmacogenomics: getting closer to a tailored therapy? 118
Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: A report of two cases 112
DNp73 alpha protects myogenic cells from apoptosis 108
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris 107
Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment 96
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy 94
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis 91
BRodalumab effectiveness in psoriatic patients that experienced anti-IL17 Intra-Class failure: a multicentre, retrospective study (BRIC - Study) IL-PSO (Italian Landscape Psoriasis) 90
HLA-C*06 and response to ustekinumab in Caucasian patients with psoriasis: Outcome and long-term follow-up 88
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 85
Gender Influence on Bimekizumab Response in Patients with Psoriasis: Results of a Real-World Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis) 83
Keratosis punctata palmoplantaris and malignancies: case report 83
Totale 26.248
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.291
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.291
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202175 0 0 0 0 0 0 0 0 0 0 0 75
2021/20221.136 34 90 111 62 29 116 43 59 83 121 59 329
2022/20231.513 166 132 83 245 134 312 83 74 149 6 94 35
2023/2024519 73 18 29 19 42 140 21 68 3 5 6 95
2024/20252.028 114 420 214 156 38 151 161 98 171 148 194 163
2025/20263.869 353 229 516 311 283 129 460 387 461 446 211 83
Totale 26.658